PanCAN Chief Scientific & Medical Officer Dr. Anna Berkenblit shares new consensus statements for the diagnosis and ...

PanCAN Patient Services Case Manager Trishana Horton offers some suggestions for how to navigate conversations with loved ...

Pancreatic cancer patients who undergo surgery for pancreatic cancer often have many questions and concerns about post-operative nutritional care. Most importantly, patients and their caregivers ...

Enzymes are proteins secreted by the pancreas to break down the food we eat. Often, pancreatic tumors prevent this process, causing enzyme insufficiency. Treatments for pancreatic cancer can also be a ...

Cancer cachexia impacts almost 90% of people living with pancreatic cancer. Learn more about this condition in this Q&A with Nicolas Clifford, PanCAN’s manager of research and education communication.

The types of cancer people are getting and dying from most may be changing in the next 20 years, according to a new study. Published today in JAMA Network Open, PanCAN and our research partners at ...

Editor’s note: The “Research Spotlight” series is written by Dr. Anna Berkenblit, PanCAN’s Chief Scientific and Medical Officer. Each month, Dr. Berkenblit shares her insights into the latest news and ...

For the third year in the row, the five-year survival rate for pancreatic cancer has increased one percentage point, according to the American Cancer Society’s Cancer Facts & Figures 2024 Report ...

They are orange, they are flavorful and packed-full of nutrition – sweet potatoes are sure to add a pop of color to your plates in the upcoming holiday season. These root vegetables are available year ...

Editor’s note: It’s been 12 years since the passing of Steve Jobs. This blog, published two years ago, discusses the rare form of pancreatic cancer Jobs had, pancreatic neuroendocrine tumor. It’s been ...

The U.S. Food and Drug Administration (FDA) has approved a wearable medical device used in combination with a standard chemotherapy regimen for the treatment of adult patients with locally advanced ...

For the first time in more than a decade, the FDA has approved a new first-line treatment for patients with metastatic pancreatic cancer. After a clinical trial showed a positive survival benefit, the ...